CC
NTRP

Cannell & Co’s Neurotrope, Inc. Common NTRP Stock Holding History

Cannell & Co’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-127,420
Closed -$141K – 283
2020
Q3 		$141K Hold
127,420
– – 0.01% 236
2020
Q2 		$148K Hold
127,420
– – 0.01% 230
2020
Q1 		$104K Sell
127,420
-7,500
-6% -$8.18K 0.01% 222
2019
Q4 		$133K Sell
134,920
-62,761
-32% -$48.9K ﹤0.01% 234
2019
Q3 		$160K Sell
197,681
-31,800
-14% -$146K 0.01% 230
2019
Q2 		$1.84M Buy
229,481
+16,100
+8% +$108K 0.07% 129
2019
Q1 		$1.16M Buy
213,381
+25,000
+13% +$107K 0.05% 146
2018
Q4 		$673K Sell
188,381
-92,412
-33% -$560K 0.03% 175
2018
Q3 		$2.47M Buy
280,793
+10,000
+4% +$95.7K 0.09% 129
2018
Q2 		$2.62M Hold
270,793
– – 0.1% 123
2018
Q1 		$2.2M Buy
270,793
+33,600
+14% +$267K 0.08% 128
2017
Q4 		$1.67M Buy
237,193
+86,400
+57% +$503K 0.06% 144
2017
Q3 		$778K Buy
150,793
+26,000
+21% +$136K 0.03% 183
2017
Q2 		$1.17M Buy
124,793
+62,000
+99% +$662K 0.04% 161
2017
Q1 		$1.2M Buy
+62,793
New +$1.19M 0.04% 163

Other funds holding NTRP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Cannell & Co's NTRP Position: Q4 2020 in Review

Cannell & Co sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 127,420 shares — an estimated $141K sold.

Cannell & Co first reported a position in NTRP in Q1 2017 and held it in 15 quarters. The position peaked at $2.62M in Q2 2018. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

  • Cannell & Co reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
  • Cannell & Co sold 127,420 Neurotrope, Inc. Common shares in Q4 2020, an estimated $141K.
  • Cannell & Co first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 15 quarters.
  • Cannell & Co's Neurotrope, Inc. Common position peaked at $2.62M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on Cannell & Co's 13F filing for Q4 2020, filed 11 Feb 2021.